Bayesian Capital Management, LP Chroma Dex Corp. Transaction History
Bayesian Capital Management, LP
- $463 Million
- Q3 2025
A detailed history of Bayesian Capital Management, LP transactions in Chroma Dex Corp. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,200 shares of CDXC stock, worth $68,768. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,200
Previous 14,500
22.76%
Holding current value
$68,768
Previous $89,000
23.6%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CDXC
# of Institutions
174Shares Held
30.9MCall Options Held
121KPut Options Held
55.6K-
Vanguard Group Inc Valley Forge, PA4.02MShares$24.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.65MShares$10.1 Million4.08% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.44MShares$8.82 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...